Clinically proven sleep training, digitally delivered
Somryst (somryst.com) scores 66 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Technology brands, in the 13th percentile of 18642 Healthcare brands.
Somryst is a digital therapeutic developed for adults aged 22 and older in the United States who experience chronic insomnia. It is the first FDA-cleared digital treatment for this condition, delivering clinically proven cognitive behavioral therapy techniques through lessons and activities accessible via smartphone or tablet. Positioned as an alternative to traditional drug-based sleep aids, Somryst aims to retrain the brain for better sleep using structured, evidence-based methods rather than medication.
| Brand Name | Somryst |
|---|---|
| Domain | somryst.com |
| Industry | Healthcare, Technology |
| Main Competitors | Sleepio (73/100), Calm (93/100), Headspace (95/100), SleepScore Labs (82/100) |
Moz Domain Authority 42/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Learn about Somryst, the first FDA cleared digital treatment indicated to treat chronic insomnia in people aged 22 and older." (Meta description: 20 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Next.js.
Social footprint: verified profiles on Facebook, Instagram, YouTube; no detected presence on X (Twitter), LinkedIn, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Somryst?", Claude could identify the brand as of October 2026. Somryst is a prescription digital therapeutic developed by Pear Therapeutics for treating chronic insomnia in adults, delivering cognitive behavioral therapy for insomnia (CBT-I) through a smartphone app. It was notable as one of the first FDA-authorized prescription digital ther Best known for Being an FDA-cleared prescription app delivering CBT-I for chronic insomnia.
When asked "Best brands similar to Somryst?", Claude would recommend Somryst as of October 2026. It's a pioneering and well-known example of a prescription digital therapeutic for insomnia, so it's relevant when discussing similar digital health or sleep treatment brands.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Somryst's main competitors in Healthcare: Sleepio (73/100), Calm (93/100), Headspace (95/100), SleepScore Labs (82/100).
Sources: Brand Analyzer scan
Somryst is the first FDA-cleared digital treatment indicated for chronic insomnia in people aged 22 and older. It delivers clinically proven sleep training lessons and activities through a smartphone or tablet, functioning as a digital therapeutic rather than a traditional sleep aid.
Sources: Somryst official site
Somryst has low AI-search visibility, scoring 21/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 29, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Somryst official site
Somryst offers a single digital therapeutic product: an app-based treatment program delivered via smartphone or tablet. It includes structured lessons and activities based on cognitive behavioral techniques designed to treat chronic insomnia.
Sources: Somryst official site
Somryst provides a structured, app-based program that trains the brain for better sleep using cognitive behavioral techniques. It delivers lessons and activities directly through a smartphone or tablet to help users manage and reduce chronic insomnia symptoms over time.
Sources: Somryst official site
Somryst scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Somryst official site
Somryst is known for being the first FDA-cleared digital treatment for chronic insomnia, distinguishing it from conventional medication-based sleep aids. It is recognized for offering a clinically validated, technology-driven approach to insomnia treatment.
Sources: Somryst official site
Somryst can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Somryst official site
Somryst is used by adults aged 22 and older in the United States who suffer from chronic insomnia and are seeking a non-drug, clinically validated treatment option instead of traditional sleep medications.
Sources: Somryst official site
Somryst scores 21/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Somryst has a weak AI-visibility profile at 21/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is visibility (0/100). It benefits from a Moz Domain Authority of 42/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and thin schema.org structured data. In a live check, Claude could already identify Somryst from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Somryst: Solimat (66/100), Hampshire and Isle of Wight Healthcare NHS Foundation Trust (66/100), Sonavi Labs (66/100), Sonic HealthPlus (66/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.